Life Science Global News

One News Hub for the Entire Life Sciences Economy

Life Sciences Global News (LSGN) is a global B2B life sciences news and analysis platform for executives, investors, scientists, and policymakers. We connect biotech, pharma, medtech, diagnostics, digital health, food science, and sustainability—delivering global life sciences news, market intelligence, and executive insight that help leaders make better decisions.

Our Story

LSGN is published by Blue Manta Media Limited, a UK-based specialist media company building niche publications that support the UN Sustainable Development Goals (SDGs).

  • 2021 — H2O Global News launched to spotlight water, wastewater, and water-tech innovation.
  • 2023 — Climate Global News expanded our coverage to climate solutions, clean tech, and environmental policy.
  • 2025 — Life Sciences Global News extends the mission to the life sciences industry, where discovery, clinical development, and commercialization intersect with public health, sustainability, and the global economy.

Across our brands—H2O Global News, Climate Global News, and Life Sciences Global News—we tell stories that move industries forward.

What We Cover (and Why It Matters)

We track the end-to-end life sciences value chain—from discovery to market scale—so you see the full picture, not just a single silo. Core beats include:

  • Biotechnology News & Trends: cell and gene therapy, mRNA and RNA therapeutics, CRISPR, synthetic biology, bioprocessing and CMC, platform technologies, manufacturing scale-up.
  • Pharma & Clinical Development: clinical trials news (phase updates), regulatory approvals (FDA, EMA, MHRA), safety and pharmacovigilance, HEOR/market access, precision medicine.
  • Medical Devices & Diagnostics: IVD innovations, imaging and surgical tech, regulatory updates (CE Mark, 510(k), IVDR), connected devices, wearables.
  • Digital Health & Health Tech: AI in healthcare, real‑world evidence, telehealth, EHR/interop, cybersecurity, data governance.
  • Laboratory Science & Tools: analytical instruments, lab automation and robotics, reagents and consumables, quality and standards.
  • Finance & Investment: biotech funding, venture capital, M&A, IPOs, licensing and partnerships, CDMO/CRO landscape, strategic alliances.
  • Policy, Ethics & Regulation: global health policy, IP and data governance, bioethics, pricing and reimbursement, sustainability regulation and ESG in life sciences.
  • Food & Beverage Science, AgriTech & Bioeconomy: functional ingredients, nutraceuticals, novel foods, fermentation, sustainable biomanufacturing.

What Makes LSGN Different

  • Global-first coverage: Europe, North America, APAC, LATAM, MENA, and Africa—because innovation is borderless.
  • Cross-sector intelligence: We connect biotech, pharma, medtech, diagnostics, digital health, and food science to reveal convergence and new value chains.

Our Mission & Values

  • Clarity: Cut through noise with plain-English explanations and actionable insights.
  • Coverage with purpose: Highlight innovations that improve health outcomes and support a sustainable bioeconomy.
  • Community: Elevate diverse voices across regions and disciplines.

Contribute or Pitch a Story

We welcome pitches from scientists, clinicians, policymakers, and industry experts. Send ideas, data, or commentary to editorial@lifesciencesglobalnews.com. Please include: topic, why it matters, and any conflicts of interest.